69
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Origanum Compactum Essential Oil Ameliorates Triton WR-1339-Induced Hyperlipidemia in Rats: Chemical Composition and Acute Toxicity

, , , &
Pages 132-144 | Received 31 Aug 2023, Published online: 17 Oct 2023
 

ABSTRACT

The impact of Origanum compactum essential oil (EO) at 80 mg kg−1 on Triton WR-1339-induced hyperlipidemia in rats was investigated.The EO’s phytochemical composition revealed the predominance of carvacrol (35.71%), p-cymene (13.74%), and carvacrol methyl ether (11.71%). Triton WR-1339 led to elevations in total cholesterol (TC), triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), as well asatherogenic indices encompassing the atherogenic coefficient (AC), Castelli’s risk index I (CRI-I), and Castelli’s risk index II (CRI-II). Conversely, pretreatment with O. Compactum EO for sevendays exerted a preventive effect against the increase of TC, TGs, LDL-C, VLDL-C, AC, CRI-I.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Ethics Approval

All experiments were performed according to the local ethical committee, Faculty of Science and Techniques Errachidia, Morocco, number FSTE/2015.

Abbreviations

AC=

Atherogenic coefficient

CRI=

Castelli’s risk index

EO=

Essential oil

HDL-C=

High-density lipoprotein cholesterol

HMG-CoA reductase=

Hydroxymethyl-glutaryl coenzyme A reductase

LDL-C=

Low-density lipoprotein cholesterol

TC=

Total cholesterol

TGs=

Triglycerides

VLDL-C=

Very-low-density lipoprotein cholesterol

Additional information

Funding

This work was supported by the CNRST under grant N° PPR/2015/35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.